Annual Certification of Compliance with the Corporate Comprehensive Compliance Program for California
Philips Healthcare, a division of Philips Electronics North America Corp., and its affiliates (“Philips”), has established and is operating under a Comprehensive Compliance Program (“CCP”).
Where applicable, is in accordance with the “Compliance Program Guidance for Pharmaceutical Manufacturers” issued by the United States Department of Health and Human Services Office of Inspector General (“CPG”), and the AdvaMed and NEMA/MITA Codes of Ethics on Interactions with Healthcare Providers (“Device Industry Codes”).
Not a drug manufacturer
Because Philips is a medical device manufacturer – not a drug manufacturer – certain guidance set forth in the CPG does not apply to Philips and its operations. Similarly, Philips’ CCP is based on Device Industry Codes and not the PhRMA Code of Ethics for the pharmaceutical industry.
With these clarifications and Philips’ good faith understanding of the statutory requirements, Philips is – to the best of its knowledge – in compliance with the provisions of the California Health and Safety Code §§119400-119402, to the extent they apply to Philips Healthcare.
[Updated 03-04-2014]
Compliance updates
Please note that our Philips Healthcare compliance program may vary from country to country to reflect legal differences, and not all programs are available for posting.
What's trending
@PhilipsHealth
News
Philips showcases impact of tele-ultrasound advancing Precision Diagnosis at AIUM virtual event
Click to read morePhilips and Ibex Medical Analytics team to accelerate adoption of AI-powered digital pathology
Click to read morePhilips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System receives FDA 510(k) clearance
Click to read more